Physician profile
James C Tyson
NPI 1366447047
$1,878.03
in general payments reported to CMS, 2019-2025
18 companies · $607 in 2025
The $607 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.16 · 2020: $47.33 · 2021: $206 · 2022: $208 · 2023: $182 · 2024: $544 · 2025: $607.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,252 · Education: $80.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,251.73 |
| Education | $80.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $483.32 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $473.01 | 2019-2025 | Dupixent |
| Genzyme Corporation | $422.75 | 2021-2025 | |
| Inspire Medical Systems, INC. | $185.27 | 2024-2025 | Inspire |
| Stryker Corporation | $46.94 | 2021 | |
| Smith+Nephew, INC. | $42.44 | 2019 | |
| Intersect Ent, INC. | $31.39 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $21.68 | 2025 | Neffy |
| Ambu INC. | $20.94 | 2023 | |
| Phadia US INC. | $19.70 | 2022 | |
| Integra Lifesciences Corporation | $19.42 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Optinose US, INC. | $19.29 | 2021 | |
| Alk-Abello, INC | $16.57 | 2019 | |
| Amgen INC. | $16.53 | 2025 | Tezspire |
| Aerin Medical INC. | $15.94 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $15.85 | 2024 | Ryaltris |
| Astrazeneca Pharmaceuticals LP | $13.76 | 2025 | Tezspire |
| Kaleo, INC. | $13.23 | 2024 | Auvi-Q |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Tyson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.